资讯
Sun Pharmaceutical Industries Ltd. settled claims worth $200 million in an antitrust case in Pennsylvania alleging that the ...
Indian pharma is hoping to cash in. Generic firms, such as Biocon, are already offering weight-loss drugs, such as cheaper ...
12 小时
Zacks Investment Research on MSNTEVA Q2 Earnings Beat, Revenues Miss on Lower Generics SalesTeva Pharmaceutical Industries TEVA reported second-quarter 2025 adjusted earnings of 66 cents per share, which beat the ...
Ajanta Pharma reported a 4% year-on-year increase in its consolidated profit after tax, reaching Rs 255 crore for the first ...
Generics account for nearly 90% of pharmaceutical sales by volume in the U.S. and 80% in Germany. The range is between 85 and 90% in developing countries such as China, India, Russia, Turkey, and ...
In a world of skyrocketing prescription drug prices, cheaper generics have acted as a crucial counterweight. But in Bottle of Lies, investigative journalist and author Katherine Eban exposes the ...
But as low-cost generics made in India and China became widely available through Uganda’s government and international aid agencies in the early 2000s, it seemed at first like the supply issue ...
From the Analyst's Couch Published: December 2005 Authorized Generics Gregory Glass Nature Reviews Drug Discovery 4, 953–955 (2005) Cite this article ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果